Participate in Research

Browse Clinical Trials
CAPTIVA Study for Stroke Patients
Protocol: STUDY00006284
Full Title
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA
Description
The University at Buffalo's Neurology Department is working on a study funded by the National Institute of Health. This study is for adults who have had a stroke because their brain's blood vessels were severely narrowed. It's a special type of study where neither the participants nor the researchers know who gets which treatment, which is decided randomly, like tossing a coin. The aim is to see if using different medications together can help prevent blood clots, and this will be combined with medicine and advice on how to live healthier.

The study will last about a year, and people who join will be split into three groups. One group will get aspirin and ticagrelor, another will get aspirin and rivaroxaban, and the last group will get aspirin and clopidogrel. Throughout the year, they'll need to give blood samples and answer some questionnaires. The team running the study will also help them make healthy changes in their lifestyle and manage other health risks. The findings could help doctors prevent strokes better in the future for people with similar health issues.
Compensation: No
Eligibility
Adults at least 30 years of age Had a stroke within the last 30 days
Age Group: Adults
Principal Investigator: AMIT KANDEL
ClinicalTrials.gov: Open Study
Contact(s)
AMIT KANDEL
akandel@buffalo.edu
+1 716-859-7540

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login